Abstract
Pseudomonas aeruginosa is recognized as a common causative organism in ventilator-associated pneumonia (VAP) in the critically ill, accounting for 16 to 31% of reported cases [1–4]. In addition, Ps. aeruginosa pneumonia carries with it an overall mortality of approximately 70% [2, 5–8] and an excess mortality of more than 40% [9]. By these observations alone, Ps. aeruginosa pneumonia represents one of the most serious clinical problems facing the intensive care clinician today. The high mortality rate associated with Ps. aeruginosa pneumonia persists despite the availability of potent anti-pseudomonal antibiotics and the resources of modern intensive care.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Torres A, De la Bellacasa J, Rodriguez-Roisin R, De Anta MTJ, Agusti Vidal A (1988) Diagnostic value of telescoping plugged catheters in mechanically ventilated patients with bacterial pneumonia using the Metras catheter. Am Rev Respir Dis 138: 117–120
Fagon JY, Chastre J, Domart Y, et al (1989) Nosocomial pneumonia in patients receiving continuous mechanical ventilation. Prospective analysis of 52 episodes with use of a protected brush specimen and quantitative culture techniques. Am Rev Respir Dis 139: 877–884
A’Court C, Garrard C (1992) A simplified lavage technique for microbiological surveillance of the lung. Clin Intensive Care 4: 31 (Abst)
A’Court C, Garrard C, Crook D, et al (1993) Microbiological surveillance of the lungs using non-directed bronchial lavage. Quart J Med 86: 635–648
Stevens RM, Teres D, Skillman J, Feingold D (1974) Pneumonia in an ICU: A thirty-month experience. Arch Int Med. 134: 106–111
Bryan CS, Reynolds KL (1984) Bacteremic nosocomial pneumonia. Analysis of 172 episodes from a single metropolitan area. Am Rev Respir Dis 129: 668–671
Brewer SC, Wunderink RG, Jones CB, Leeper KV (1996) Ventilator-associated pneumonia due to Pseudomonas Aeruginosa. Chest 109: 1019–1029
A’Court C, Garrard CS (1992) Nosocomial pneumonia in the intensive care unit: Mechanisms and significance. Thorax, 47: 465–473
Fagon JY, Chastre J, Hance AJ, Domart Y, Trouillet JL, Gibert C (1993) Evaluation of clinical judgement in the identification and treatment of nosocomial pneumonia in ventilated patients. Chest 103: 547–553
Pollack M (1995) Pseudomonas aeruginosa. In: Mandell GL, Bennett GE (eds) Principles and Practice of Infectious Diseases. Churchill Livinstone, New York, pp 1980–2003
Morrison AJ, Wenzel R (1984) Epidemiology of infections due to Pseudomonas aeruginosa. Rev Infect Dis 6: S627–5642
British Thoracic Society Research Committee and the Public Health Laboratory Service (1992) The aetiology, management and outcome of severe community-acquired pneumonia on the intensive therapy unit. Respir Med 86: 7–13
Johanson WG, Pierce AK, Sanford JP (1969) Changing pharyngeal bacterial flora of hospitalized patients. N Engl J Med 21: 1137–1140
Ismaeel NA (1993) Colonization of intensive care unit patients by Pseudomonas aeruginosa. J Hosp Infection 25: 279–286
Vincent JL, Bihari DJ, Suter PM et al (1995) The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 274: 639–644
Rello J, Ausina V, Ricart M, et al (1994) Risks factors for infection by Pseudomonas aeruginosa in patients with ventilator-associated pneumonia. Intensive Care Med 20: 193–198
Cross A, Allen JR, Burke J, et al (1983) Nosocomial infections due to Pseudomonas aeruginosa: Review of recent trends. Rev Infect Dis 5 (Suppl 5): S837–S845.
Johanson WG, Peirce AK, Sanford JP, et al (1972) Nosocomial respiratory infections with Gram-negative bacilli: The significance of colonization of the respiratory tract. Ann Intern Med 77: 701–706
Woods DE, Straus DC, Johanson WG, Bass JA (1981) Role of salivary protease activity in adherence of Gram-negative bacilli to mammalian buccal epithelial cells in vivo. J Clin Invest 68: 1435–1440
Driks MR, Craven DE, Celli BR, et al (1987) Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers. The role of gastric colonization. N Engl J Med 317: 1376–1382
Cook DJ, Laine LA, Guyatt GH, Raffin TA (1991) Nosocomial pneumonia and the role of gastric pH. A meta-analysis. Chest 100: 7–13
Craven DE, Daschner FD (1989) Nosocomial pneumonia in the intubated patient: Role of gastric colonization. Eur J Clin Microbial Infect Dis 8: 40–50
Garrard CS, Crook DWM (1991) Nosocomial pneumonia in the critically ill. Curr Anaesth Crit Care 2: 155–160
Foster TJ, McDevitt D (1994) Molecular basis of adherence of Staphylococci to biomaterials. In: Bisno AL, Waldvogel FA (eds) Infections associated with indwelling medical devices. Am Soc Microbiol: Washington, pp 31–44
Woods DE, Bass JA, Johanson WG, Straus DC (1980) Role of adherence in the pathogenesis of Pseudomonas aeruginosa lung infection in cystic fibrosis patients. Infection Immun 30: 694–699
Johanson WG, Higuchi JH, Chaudhuri TR, Woods DE (1980) Bacterial adherence to epithelial cells in bacillary colonization of the respiratory tract. Am Rev Respir Dis 121: 55–63
Saiman L, Cacalano G, Prince A (1990) Pseudomonas cepacia adherence to respiratory epithelial cells is enhanced by Pseudomonas aeruginosa. Infect Immun 58: 2578–2584
Woods DE, Straus DC, Johanson WG, Berry BK, Bass JA (1980) Role of pili in adherence of Pseudomonas aeruginosa to mammalian buccal epithelial cells. Infection Immun 29: 1146–1151
Woods DE, Straus DC, Johanson WG Jr, Bass JA (1983) Factors influencing the adherence of Pseudomonas aeruginosa to mammalian buccal epithelial cells. Rev Infect Dis 5 (Suppl 5): S846–5851
Doig P, Todd T, Sastry PA, et al (1988) Role of pili in adhesion of Pseudomonas aeruginosa to human respiratory epithelial cells. Infect Immun 56: 1641–1646
Irvin RT, Doig P, Lee KK et al (1989) Characterization of the Pseudomonas aeruginosa pilus adhesin: Confirmation that the pilin structural protein subunit contains a human epithelial cell-binding domain. Infect Immun 57: 3720–3726
Farinha MA, Conway BD, Glasier LMG, et al (1994) Alteration of the pilin adhesin of Pseudomonas aeruginosa PAO results in normal pilus biogenesis but a loss of adherence to human pneumocyte cells and decreased virulence in mice. Infection Immun 62: 4118–4123
Tang H, Kays M, Prince A (1995) Role of Pseudomonas aeruginosa pili in acute pulmonary infection. Infect Immun 63: 1278–1285
Landsperger WJ, Kelly-Wintenberg KD, Montie TC, et al (1994) Inhibition of bacterial motility with human antiflagellar monclonal antibodies attenuates Pseudomonas aeruginosa-induced pneumonia in the immunocompetent rat. Infection Immun 62: 4825–4830
Ramphal R, Pier GB (1985) Role of Pseudomonas aeruginosa mucoid exopolysaccharide in adherence to tracheal cells. Infect Immun 47: 1–4
Pollack M (1984) The virulence of Pseudomonas aeruginosa. Rev Infect Dis 6: S617–S626
Rivera M, Nicotra MB (1982) Pseudomonas aeruginosa mucoid strain. Its significance in adult chest diseases. Am Rev Respir Dis 126: 833–836
Baker NR, Minor V, Deal C, Shahrabadi MS, Simpson DA, Woods DE (1991) Pseudomonas aeruginosa exoenzyme S is an adhesion. Infect Immun 59: 2859–2863
Tang HB, Di Mango E, Bryan R, et al (1996) Contribution of specific Pseudomonas aeruginosa virulence factors to pathogenesis of pneumonia in a neonatal mouse model of infection. Infect Immun 64: 37–43
Finlay B, Falkow S (1989) Common themes in microbial pathogenicity. Microbiol Rev 53: 210–230
Buret A, Cripps AW (1993) The immunoevasive activities of Pseudomonas aeruginosa. Relevance for cystic fibrosis. Am Rev Respir Dis 148: 793–805
Fink RBJ, Naegel GP, Matthay RA, Reynolds HY (1981) Cystic fibrosis Pseudomonas opsonins: Inhibitory nature in an in vitro phagocytic assay. J Clin Invest 68: 899–914
Biggar WD, Holmes B, Good RA (1971) Opsonic defect in patients with cystic fibrosis of the pancreas. Proc Natl Acad Sci, USA 68: 1716–1719
Thomassen M, Boxerbaum B, Demko C, Kuchenbrod P, Dearborn D, Wood R (1979) Inhibitory effect of cystic fibrosis serum on Pseudomonas phagocytosis by rabbit and human alveolar macrophages. Pediatr Res 13: 1085 1088
Garrard CS, ACourt CD (1995) The diagnosis of pneumonia in the critically ill. Chest, 108 (2 Suppl): 17S–25S
Chastre J, Fagon JY, Domart Y, Gibert C (1989) Diagnosis of nosocomial pneumonia in intensive care unit patients. Eur J Clin Microbiol Infect Dis 8: 35–39
Andrews C, Coalson J, Johanson W (1981) Diagnosis of nosocomial pneumonia in acute diffuse lung injury. Chest 1980, 80: 254–258
Pugin J, Auckenthaler R, Mili N, Janssens JP, Lew PD, Suter PM (1991) Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and non-bronchoscopic “blind” bronchoalveolar lavage fluid. Am Rev Respir Dis 143: 1121–1129
Torres A, Puig BJ, Xaubet A, et al (1989) Diagnostic value of quantitative cultures of bronchoalveolar lavage and telescoping plugged catheters in mechanically ventilated patients with bacterial pneumonia. Am Rev Respir Dis 140: 306–310
Fagon JY, Chastre J, Hance AJ, et al (1988) Detection of nosocomial lung infection in ventilated patients. Use of a protected specimen brush and quantitative culture techniques in 147 patients. Am Rev Respir Dis 138: 110–116
Salata RA, Lederman MM, Shlaes DM, et al (1987) Diagnosis of nosocomial pneumonia in intubated, intensive care unit patients. Am Rev Respir Dis 135: 426–432
Shepard K (1988) Diagnosis of pneumonia in patients with adult respiratory distress syndrome (ARDS). Chest 94: 4S (Abst)
Papazian L, Martin C, Albanese J, Saux P, Charrel J, Gouin F (1989) Comparison of two methods of bacteriologic sampling of the lower respiratory tract: A study in ventilated patients with nosocomial bronchopneumonia. Crit Care Med 17: 461–464
El Biari M, Torres A, Gonzalez J, et al (1991) Diagnosis of ventilator-associated pneumonia: Diagnostic value of quantitative culture of tracheal aspirates. Am Rev Resp Dis 143: 108 (Abst)
Torres A, Martos A, Puig BJ, et al (1993) Specificity of endotracheal aspiration, protected brush specimen, and bronchoalveolar lavage in mechanically ventilated patients. Am Rev Respir Dis 147: 952–957
Bartlett J, Alexander J, Mayhew 1 (1976) Should bronchoscopy aspirates be cultured? Am Rev Resp Dis 114: 247–251
Storer D (1984) BAL in the diagnosis of diffuse pulmonary infiltrates in the immunocompromised host. Ann Int Med 101: 1–7
Chastre J, Viau F, Brun P, et al (1984) Prospective evaluation of the protected brush specimen for the diagnosis of pulmonary infections in ventilated patients. Am Rev Respir Dis 130: 924–929
Fink MP, Snydman DR, Niederman MS, et al (1994) Treatment of severe pneumonia in hospitalized patients: Results of a multicenter, randomised, double blind trial comparing intravenous ciprofloxacin with imepenem-cilastin. The severe pneumonia study group. Antimicrob Agents Chemother 38: 547–557
Society AT (1995) Hospital-acquired pneumonia in adults: Diagnosis, assessment of severity, initial antimicrobial therapy and prevention. A consensus statement. Am J Respir Crit Care Med 153: 1711–1725
Moore RD, Smith CR, Lietman PS (1984) The association of aminoglycoside plasma levels with mortality in patients with Gram-negative bacteremia. J Infect Dis 149: 443–448
Hilf M, Yu VL, Sharp J, Zuravleff JJ, Korvick JA, Muder RR (1989) Antibiotic therapy for Pseudomonas aeruginosa bacteremia: Outcome correlations in a prospective study of 200 patients. Am J Med. 87: 540–546
Cometta A (1994) Prospective randomized comparison of imepenem monothreapy with imepenem plus netilmicin for treatment of severe infections in non-neutropenic patients. Antimicrob Agents Chemother 38: 1309–1313
Haddow A, Greene S, Heinz G, Wantuck D (1989) Ciprofloxacin (intravenous/oral) versus ceftazidime in lower respiratory tract infections. Am J Med 87: 113S–115S
Khan FA, Basir R (1989) Sequential intravenous-oral administration of ciprofloxacin vs ceftazidime in serious bacterial respiratory tract infections. Chest 96: 528–537
Wunderink R, Mayhall C, Gibert C (1992) Methodology for clinical investigation of ventilator associated pneumonia. Chest 102: 5805–588S
Montravers P, Fagon JY, Chastre J, et al (1993) Follow-up protected brushe specimens assess treatment in nosocomial pneumonia. Am Rev Respir Dis 147: 38–44
Hodson ME (1988) Antibiotic treatment. Aerosol therapy. Chest 94 (Suppl): 156S–1625
Jensen T, Pedersen SS, Garne S, Heilmann C, Hoiby N, Koch C (1987) Colistin inhalation therapy in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection. J Antimicrob Chemother 19: 831–838
Vinnicombe J, Stamey TA (1969) The relative nephrotoxicities of polymyxin B sulfate, sodium sulfomethyl-polymyxin B. sodium sulfomethyl-colistin (colymycin), and neomycin sulfate. Invest Urol 6: 505–519
Duncan IB (1974) Susceptibility of 1,500 isolates of Pseudomonas aeruginosa to gentamicin, carbenicillin, colistin, and polymyxin B. Antimicrob Agents Chemother 5: 9–15
Di Salvo AF, Stern WR (1967) Susceptibility of Pseudomonas to colistin, kanamycin and polymyxin-B. Am J Med Technol 33: 482–489
Rogers MJ, Cohen J (1986) Comparison of the binding of Gram-negative bacterial endotoxin by polymyxin B sulphate, colistin sulphate and colistin sulphomethate sodium. Infection 14: 79–81
Brown RB, Phillips D, Barker MJ, Pieczarka R, Sands M, Teres D (1989) Outbreak of nosocomial Flavobacterium meningosepticum respiratory infections associated with use of aerosolized polymyxin B. Am J Infect Control 17: 121–125
Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 40: 373–383
Kovaks K, Yu VL (1994) Anti-pseudomonal antimicrobial agent therapy. Drugs Today 30: 155–170
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Peacock, S.J., Garrard, C.S. (1997). The Challenge of Pseudomonas aeruginosa Pneumonia. In: Vincent, JL. (eds) Yearbook of Intensive Care and Emergency Medicine 1997. Yearbook of Intensive Care and Emergency Medicine, vol 1997. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-13450-4_51
Download citation
DOI: https://doi.org/10.1007/978-3-662-13450-4_51
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-13452-8
Online ISBN: 978-3-662-13450-4
eBook Packages: Springer Book Archive